Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Similar articles for PubMed (Select 17452515)

1.

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.

Nash RA, McSweeney PA, Crofford LJ, Abidi M, Chen CS, Godwin JD, Gooley TA, Holmberg L, Henstorf G, LeMaistre CF, Mayes MD, McDonagh KT, McLaughlin B, Molitor JA, Nelson JL, Shulman H, Storb R, Viganego F, Wener MH, Seibold JR, Sullivan KM, Furst DE.

Blood. 2007 Aug 15;110(4):1388-96. Epub 2007 Apr 23.

2.

Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.

Jaspers A, Baron F, Maertens J, De Prijck B, Schots R, Bonnet C, Hafraoui K, Willems É, Servais S, Fillet G, Beguin Y.

Am J Hematol. 2015 Jul;90(7):E133-4. doi: 10.1002/ajh.24013. No abstract available.

PMID:
25802012
3.

Systemic sclerosis: a systematic review on therapeutic management from 2011 to 2014.

Young A, Khanna D.

Curr Opin Rheumatol. 2015 May;27(3):241-8. doi: 10.1097/BOR.0000000000000172.

PMID:
25775190
4.

Long-term outcomes of autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis: physician's and patient's perspectives.

Shevchenko JL, Kuznetsov AN, Ionova TI, Melnichenko VY, Fedorenko DA, Kurbatova KA, Gorodokin GI, Novik AA.

Ann Hematol. 2015 Jul;94(7):1149-57. doi: 10.1007/s00277-015-2337-8. Epub 2015 Feb 25.

PMID:
25711670
5.

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.

Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stüve O, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JD.

JAMA Neurol. 2015 Feb;72(2):159-69. doi: 10.1001/jamaneurol.2014.3780.

PMID:
25546364
6.

Acquired haemophilia A in a patient with systemic sclerosis treated with autologous haematopoietic stem cell transplantation.

De Langhe E, Lenaerts J, Dierickx D, Hendrickx P, Verleden GM, Wuyts WA, Peerlinck K, Westhovens R.

Rheumatology (Oxford). 2015 Jan;54(1):196-7. doi: 10.1093/rheumatology/keu402. Epub 2014 Oct 6. No abstract available.

PMID:
25525129
7.

Cardiac assessment before stem cell transplantation for systemic sclerosis--reply.

van Laar JM, Farge D, Tyndall A.

JAMA. 2014 Nov 5;312(17):1803-4. doi: 10.1001/jama.2014.12572. No abstract available.

PMID:
25369498
8.

Cardiac assessment before stem cell transplantation for systemic sclerosis.

Burt RK, Oliveira MC, Shah SJ.

JAMA. 2014 Nov 5;312(17):1803. doi: 10.1001/jama.2014.12566. No abstract available.

PMID:
25369497
9.

Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial.

van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EW, Vonk MC, Schattenberg AV, Matucci-Cerinic M, Voskuyl AE, van de Loosdrecht AA, Daikeler T, Kötter I, Schmalzing M, Martin T, Lioure B, Weiner SM, Kreuter A, Deligny C, Durand JM, Emery P, Machold KP, Sarrot-Reynauld F, Warnatz K, Adoue DF, Constans J, Tony HP, Del Papa N, Fassas A, Himsel A, Launay D, Lo Monaco A, Philippe P, Quéré I, Rich É, Westhovens R, Griffiths B, Saccardi R, van den Hoogen FH, Fibbe WE, Socié G, Gratwohl A, Tyndall A; EBMT/EULAR Scleroderma Study Group.

JAMA. 2014 Jun 25;311(24):2490-8. doi: 10.1001/jama.2014.6368.

PMID:
25058083
10.

Autologous hematopoietic stem cell therapy in severe systemic sclerosis: ready for clinical practice?

Khanna D, Georges GE, Couriel DR.

JAMA. 2014 Jun 25;311(24):2485-7. doi: 10.1001/jama.2014.6369. No abstract available. Erratum in: JAMA. 2014 Nov 5;312(17):1805.

PMID:
25058081
11.

Connective tissue diseases: stem cell transplant prolongs systemic sclerosis survival.

Bernard NJ.

Nat Rev Rheumatol. 2014 Aug;10(8):444. doi: 10.1038/nrrheum.2014.117. Epub 2014 Jul 15. No abstract available.

PMID:
25023453
12.

ANCA-positive vasculitis as a secondary autoimmune disease after autologous stem cell transplantation for systemic sclerosis: a case report.

Schmalzing M, Amann K, Tony HP.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-222-4. Epub 2014 Jul 8.

PMID:
25005330
13.

Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations.

Henes JC, Koetter I, Horger M, Schmalzing M, Mueller K, Eick C, Bauer A, Vogel W, Kanz L.

Rheumatology (Oxford). 2014 May;53(5):919-22. doi: 10.1093/rheumatology/ket464. Epub 2014 Jan 22.

PMID:
24459219
14.

Stem cell transplantation in systemic sclerosis.

van Laar JM, Sullivan K.

Curr Opin Rheumatol. 2013 Nov;25(6):719-25. doi: 10.1097/01.bor.0000434669.32150.ac. Review.

PMID:
24047607
15.

[Treatment and course of a man with systemic sclerosis before and after hematopoetic blood stem cell transplantation].

Blank N, Lorenz HM.

Dtsch Med Wochenschr. 2013 Sep;138(37):1824-7. doi: 10.1055/s-0033-1349503. Epub 2013 Sep 4. German.

PMID:
24006162
16.

Update on stem cell transplantation for systemic sclerosis: recent trial results.

Naraghi K, van Laar JM.

Curr Rheumatol Rep. 2013 May;15(5):326. doi: 10.1007/s11926-013-0326-2. Review.

PMID:
23516015
17.

Recent advances in the diagnosis and treatment of systemic sclerosis.

Kowal-Bielecka O, Bielecki M, Kowal K.

Pol Arch Med Wewn. 2013;123(1-2):51-8. Epub 2013 Jan 21. Review.

18.

Molecular targets for therapy in systemic sclerosis.

Iwamoto N, Distler O.

Fibrogenesis Tissue Repair. 2012 Jun 6;5(Suppl 1):S19. doi: 10.1186/1755-1536-5-S1-S19. eCollection 2012.

19.

Remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation.

Hasselblatt P, Drognitz K, Potthoff K, Bertz H, Kruis W, Schmidt C, Stallmach A, Schmitt-Graeff A, Finke J, Kreisel W.

Aliment Pharmacol Ther. 2012 Oct;36(8):725-35. doi: 10.1111/apt.12032. Epub 2012 Sep 2.

PMID:
22937722
20.

Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.

Nademanee AP, DiPersio JF, Maziarz RT, Stadtmauer EA, Micallef IN, Stiff PJ, Hsu FJ, Bridger G, Bolwell BJ.

Biol Blood Marrow Transplant. 2012 Oct;18(10):1564-72. doi: 10.1016/j.bbmt.2012.05.017. Epub 2012 Jun 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk